ReviewInternational journal of oncology2025

Targeting ncRNAs to overcome metabolic reprogramming‑mediated drug resistance in cancer (Review).

Junxin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.